These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 29878908)

  • 21. [Diagnostic use of functional imaging in Parkinson's disease and related disorders].
    Hanakawa T; Kawasaki K; Hashikawa K; Fukuyama H
    Nihon Rinsho; 2004 Sep; 62(9):1733-8. PubMed ID: 15462394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Not Available].
    Prange S; Hermier M; Danaila T; Laurencin C; Thobois S
    Presse Med; 2017 Mar; 46(2 Pt 1):202-209. PubMed ID: 28040345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can neuroimaging predict dementia in Parkinson's disease?
    Lanskey JH; McColgan P; Schrag AE; Acosta-Cabronero J; Rees G; Morris HR; Weil RS
    Brain; 2018 Sep; 141(9):2545-2560. PubMed ID: 30137209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Update on Molecular Imaging in Parkinson's Disease.
    Liu ZY; Liu FT; Zuo CT; Koprich JB; Wang J
    Neurosci Bull; 2018 Apr; 34(2):330-340. PubMed ID: 29282614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Research progress in the early diagnosis of Parkinson's disease.
    Xie L; Hu L
    Neurol Sci; 2022 Nov; 43(11):6225-6231. PubMed ID: 35948779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnetic resonance and dopamine transporter imaging for the diagnosis of Parkinson´s disease: a narrative review.
    Otani RTV; Yamamoto JYS; Nunes DM; Haddad MS; Parmera JB
    Arq Neuropsiquiatr; 2022 May; 80(5 Suppl 1):116-125. PubMed ID: 35976320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical criteria for subtyping Parkinson's disease: biomarkers and longitudinal progression.
    Fereshtehnejad SM; Zeighami Y; Dagher A; Postuma RB
    Brain; 2017 Jul; 140(7):1959-1976. PubMed ID: 28549077
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of dopaminergic terminal dysfunction and microstructural abnormalities of the basal ganglia and the olfactory tract in Parkinson's disease.
    Scherfler C; Esterhammer R; Nocker M; Mahlknecht P; Stockner H; Warwitz B; Spielberger S; Pinter B; Donnemiller E; Decristoforo C; Virgolini I; Schocke M; Poewe W; Seppi K
    Brain; 2013 Oct; 136(Pt 10):3028-37. PubMed ID: 24014521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional imaging in Parkinson's disease and dementia with Lewy bodies.
    Colloby S; O'Brien J
    J Geriatr Psychiatry Neurol; 2004 Sep; 17(3):158-63. PubMed ID: 15312279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Position Emission Tomography/Single-Photon Emission Tomography Neuroimaging for Detection of Premotor Parkinson's Disease.
    Zou J; Weng RH; Chen ZY; Wei XB; Wang R; Chen D; Xia Y; Wang Q
    CNS Neurosci Ther; 2016 Mar; 22(3):167-77. PubMed ID: 26776081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroimaging in Parkinson's disease.
    Stoessl AJ
    Neurotherapeutics; 2011 Jan; 8(1):72-81. PubMed ID: 21274687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Future of Brain Imaging in Parkinson's Disease.
    Helmich RC; Vaillancourt DE; Brooks DJ
    J Parkinsons Dis; 2018; 8(s1):S47-S51. PubMed ID: 30584163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of neuroimaging in the early diagnosis and evaluation of Parkinson's disease.
    Seibyl J; Jennings D; Tabamo R; Marek K
    Minerva Med; 2005 Oct; 96(5):353-64. PubMed ID: 16227950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroimaging in Parkinson's disease.
    Brooks DJ
    NeuroRx; 2004 Apr; 1(2):243-54. PubMed ID: 15717025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroimaging of Parkinson's disease: Expanding views.
    Weingarten CP; Sundman MH; Hickey P; Chen NK
    Neurosci Biobehav Rev; 2015 Dec; 59():16-52. PubMed ID: 26409344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iron- and Neuromelanin-Weighted Neuroimaging to Study Mitochondrial Dysfunction in Patients with Parkinson's Disease.
    Pizarro-Galleguillos BM; Kunert L; Brüggemann N; Prasuhn J
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imaging the aetiology of sleep disorders in dementia and Parkinson's disease.
    Pavese N
    Curr Neurol Neurosci Rep; 2014 Dec; 14(12):501. PubMed ID: 25341374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear imaging in Parkinson's disease: The past, the present, and the future.
    Golan H; Volkov O; Shalom E
    J Neurol Sci; 2022 May; 436():120220. PubMed ID: 35313223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional imaging studies of non-motoric manifestations of Parkinson's Disease.
    Stoessl AJ
    Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S13-6. PubMed ID: 20082973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroimaging of depression in Parkinson's disease: a review.
    Chagas MH; Linares IM; Garcia GJ; Hallak JE; Tumas V; Crippa JA
    Int Psychogeriatr; 2013 Dec; 25(12):1953-61. PubMed ID: 23992107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.